(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
The Nasdaq Global Market |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Date File (embedded within the Inline XBRL document) |
SI-BONE, INC. | |||||||||||
Date: | May 1, 2023 | By: | /s/ Anshul Maheshwari | ||||||||
Anshul Maheshwari | |||||||||||
Chief Financial Officer | |||||||||||
(Principal Financial and Accounting Officer) |
Three Months Ended March 31, | |||||||||||
2023 | 2022 | ||||||||||
Revenue | $ | 32,708 | $ | 22,439 | |||||||
Cost of goods sold | 5,924 | 2,983 | |||||||||
Gross profit | 26,784 | 19,456 | |||||||||
Operating expenses: | |||||||||||
Sales and marketing | 27,313 | 25,605 | |||||||||
Research and development | 3,291 | 3,580 | |||||||||
General and administrative | 7,473 | 7,139 | |||||||||
Total operating expenses | 38,077 | 36,324 | |||||||||
Loss from operations | (11,293) | (16,868) | |||||||||
Interest and other income (expense), net: | |||||||||||
Interest income | 932 | 73 | |||||||||
Interest expense | (838) | (561) | |||||||||
Other income (expense), net | 74 | (54) | |||||||||
Net loss | $ | (11,125) | $ | (17,410) | |||||||
Net loss per share, basic and diluted | $ | (0.32) | $ | (0.52) | |||||||
Weighted-average number of common shares used to compute basic and diluted net loss per share | 34,916,106 | 33,792,326 |
March 31, 2023 | December 31, 2022 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 22,969 | $ | 20,717 | |||||||
Short-term investments | 62,997 | 76,573 | |||||||||
Accounts receivable, net | 22,600 | 20,674 | |||||||||
Inventory | 17,790 | 17,282 | |||||||||
Prepaid expenses and other current assets | 2,045 | 2,365 | |||||||||
Total current assets | 128,401 | 137,611 | |||||||||
Property and equipment, net | 16,629 | 15,564 | |||||||||
Operating lease right-of-use assets | 3,672 | 4,002 | |||||||||
Other non-current assets | 374 | 375 | |||||||||
TOTAL ASSETS | $ | 149,076 | $ | 157,552 | |||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 5,331 | $ | 6,279 | |||||||
Accrued liabilities and other | 9,896 | 13,511 | |||||||||
Operating lease liabilities, current portion | 1,401 | 1,388 | |||||||||
Total current liabilities | 16,628 | 21,178 | |||||||||
Long-term borrowings | 35,938 | 35,171 | |||||||||
Operating lease liabilities, net of current portion | 2,525 | 2,871 | |||||||||
Other long-term liabilities | 26 | 30 | |||||||||
TOTAL LIABILITIES | 55,117 | 59,250 | |||||||||
Stockholders' Equity: | |||||||||||
Common stock and additional paid-in capital | 461,889 | 455,175 | |||||||||
Accumulated other comprehensive income | 300 | 232 | |||||||||
Accumulated deficit | (368,230) | (357,105) | |||||||||
TOTAL STOCKHOLDERS’ EQUITY | 93,959 | 98,302 | |||||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 149,076 | $ | 157,552 |
Three Months Ended March 31, | ||||||||||||||
2023 | 2022 | |||||||||||||
Net loss | $ | (11,125) | $ | (17,410) | ||||||||||
Interest income | (932) | (73) | ||||||||||||
Interest expense | 838 | 561 | ||||||||||||
Depreciation and amortization | 1,086 | 713 | ||||||||||||
Stock-based compensation | 6,194 | 5,507 | ||||||||||||
Adjusted EBITDA | $ | (3,939) | $ | (10,702) | ||||||||||
Cover |
May 01, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 01, 2023 |
Entity Registrant Name | SI-BONE, INC. |
Entity Central Index Key | 0001459839 |
Amendment Flag | false |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-38701 |
Entity Tax Identification Number | 26-2216351 |
Entity Address, Address Line One | 471 El Camino Real |
Entity Address, Address Line Two | Suite 101 |
Entity Address, City or Town | Santa Clara |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 95050 |
City Area Code | 408 |
Local Phone Number | 207-0700 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | SIBN |
Entity Emerging Growth Company | false |
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end
NTZA3\;C6^)M/Y70#1*>6;3^C-A0XC="'-):^R\ WS]*%P4NV8F!F$^)8_5"9]U0WMJV(1-Z#"38L8"HD?1<^PG'^)0UQ/Y
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M'!7PAV0/XQC5!FBVJ<^AS#E%B$1L0:>S1TC,F?V)X0:O1T JLZC2Q>)XLD0
M=C<8QU6>>':+P91\E;P.Z#CV(H6:]L'1M*D'GQ$'&5E3G2[4!^Z703'V%YG]
M,8[>3^DQ+AJ!^P=,:0;I%[0V_<4[I/6K0^T, .L5R26P'+J["OGR#1S>VGDC
M.CXHPOQWD>H#_D[_ B+5-E83Z6NZ
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M4ZL.9)X[N3WUMS2A0W%;YM2,,3?0KD%X597NMU]-X6.:=R3FQPBUYL1+VWMB=-%WO
ML3